Colinz Laboratories Limited (BOM:531210)
72.56
+1.06 (1.48%)
At close: Sep 4, 2026
Colinz Laboratories Market Cap
Colinz Laboratories has a market cap or net worth of 182.79 million as of September 4, 2026. Its market cap has increased by 75.95% in one year.
Market Cap
182.79M
Enterprise Value
101.39M
Revenue
58.11M
Ranking
n/a
PE Ratio
6.53
Stock Price
72.56
ChartMarket Cap Chart
Since May 26, 2005, Colinz Laboratories's market cap has increased from 39.08M to 182.79M, an increase of 367.70%. That is a compound annual growth rate of 7.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 182.79M | 35.30% |
| Dec 31, 2025 | 135.10M | -23.12% |
| Dec 31, 2024 | 175.73M | 74.40% |
| Dec 29, 2023 | 100.76M | -48.73% |
| Dec 30, 2022 | 196.55M | 55.52% |
| Dec 31, 2021 | 126.39M | 93.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hamps Bio | 225.64M |
| Walpar Nutritions | 223.02M |
| Add-Shop E-Retail | 174.12M |
| Zenith Healthcare | 170.89M |
| Desh Rakshak Aushdhalaya | 153.28M |
| Shamrock Industrial Company | 140.84M |
| Unjha Formulations | 137.28M |
| Norris Medicines | 136.51M |